The following questions and topics will be covered in this presentation.
- What are 3 benefits to the use of buprenorphine over full opioid agonists, such as morphine, for the treatment of cancer pain?
(choose all that apply)
a) Less constipation
b) Less opioid tolerance over time
c) Less cognitive impairment
d) Affordability
- What are 3 populations for whom the use of buprenorphine may be particularly advantageous?
a) Elderly patients, patients with renal impairment, patients who are opioid naïve
b) Patients with history of SUD, patients with rapidly progressive cancer, patients with renal impairment
c) Patients without insurance, elderly, patients with history of SUD
d) Patients who are opioid naïve, patients enrolling in hospice, elderly
- True/False – Buprenorphine can be used in combination with full agonist opioids (such as morphine) to treat cancer pain.
- True/False – The equianalgesic conversions between buprenorphine and full agonist opioids is still being established, but per the package insert a Buprenorphine transdermal patch at 20 mcg/hr q weekly dose is equivalent to about 80 OME.
